These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2205708)

  • 1. Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage.
    Scolding NJ; Morgan BP; Campbell AK; Compston DA
    J Neurol Sci; 1990 Jul; 97(2-3):155-62. PubMed ID: 2205708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
    J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
    Piddlesden SJ; Morgan BP
    J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.
    Wren DR; Noble M
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):9025-9. PubMed ID: 2813437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
    Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
    Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens.
    Calder VL; Wolswijk G; Noble M
    Eur J Immunol; 1988 Aug; 18(8):1195-201. PubMed ID: 3138136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible injury of cultured rat oligodendrocytes by complement.
    Scolding NJ; Houston WA; Morgan BP; Campbell AK; Compston DA
    Immunology; 1989 Aug; 67(4):441-6. PubMed ID: 2767708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
    Scolding NJ; Morgan BP; Houston WA; Linington C; Campbell AK; Compston DA
    Nature; 1989 Jun; 339(6226):620-2. PubMed ID: 2733792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay.
    Suzumura A; Lisak RP; Silberberg DH
    J Neuroimmunol; 1986 Apr; 11(2):137-47. PubMed ID: 3949965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.
    Wing MG; Zajicek J; Seilly DJ; Compston DA; Lachmann PJ
    Immunology; 1992 May; 76(1):140-5. PubMed ID: 1378423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.
    Hirayama M; Lisak RP; Silberberg DH
    Neurology; 1986 Feb; 36(2):276-8. PubMed ID: 3945400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oligodendrocyte-type-2 astrocyte cell lineage is specialized for myelination.
    Ffrench-Constant C; Raff MC
    Nature; 1986 Sep 25-Oct 1; 323(6086):335-8. PubMed ID: 3531873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial cells as targets for cytotoxic immune mediators.
    Benn T; Halfpenny C; Scolding N
    Glia; 2001 Nov; 36(2):200-11. PubMed ID: 11596128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").
    Stangel M; Compston A; Scolding NJ
    J Neuroimmunol; 2000 Mar; 103(2):195-201. PubMed ID: 10696915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study with an anti-myelin serum. A marker for all glial cells except 'dark' oligodendrocytes.
    Roussel G; Nussbaum JL
    J Neuroimmunol; 1983 Dec; 5(3):209-26. PubMed ID: 6361066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair.
    Paz Soldán MM; Warrington AE; Bieber AJ; Ciric B; Van Keulen V; Pease LR; Rodriguez M
    Mol Cell Neurosci; 2003 Jan; 22(1):14-24. PubMed ID: 12595235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated oligodendrocyte cell death requires an astrocyte-derived cosignal.
    Zhou L; Miller RH
    J Neurosci Res; 1998 Apr; 52(2):137-48. PubMed ID: 9579404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
    Cid C; Alvarez-Cermeño JC; Salinas M; Alcázar A
    J Neurochem; 2005 Oct; 95(2):349-60. PubMed ID: 16135098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ryanodine receptors in oligodendrocytes, type 2 astrocytes, and O-2A progenitors.
    Simpson PB; Holtzclaw LA; Langley DB; Russell JT
    J Neurosci Res; 1998 May; 52(4):468-82. PubMed ID: 9589392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-2A glial progenitors from mature brain respond to CNS neuronal cell line-derived growth factors.
    Hunter SF; Bottenstein JE
    J Neurosci Res; 1991 Apr; 28(4):574-82. PubMed ID: 1870158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.